PrescriptionGiant is a FREE prescription savings program that can save you up to 75% on your prescriptions with or without insurance!

Rybrevant (Generic Amivantamab-vmjw Injection)

Actual product appearance may differ slightly.

Click the CARD below to print or take a screenshot on your mobile phone or tablet. There is no need to download another app!

If you would like to personalize your card enter your full name in the member name field below the card at this link and click the Update button.

Why is this medication prescribed?

Rybrevant (amivantamab) is prescribed for the treatment of non-small cell lung cancer (NSCLC) with a specific genetic mutation known as KRAS G12C. KRAS mutations are common in various cancers, and the G12C mutation is a specific subtype that Rybrevant targets.

Non-Small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation: Rybrevant is indicated for the treatment of adult patients with locally advanced or metastatic NSCLC with a KRAS G12C mutation, as determined by an FDA-approved test, after prior systemic therapy.

How should this medicine be used?

Rybrevant is a monoclonal antibody that targets the epidermal growth factor receptor (EGFR) exon 20 mutations. It is typically administered intravenously, and the dosing and schedule may vary based on individual patient factors and the specific treatment plan outlined by the healthcare provider.

To use Rybrevant effectively:

  • Consultation with Healthcare Provider: Always follow the recommendations and instructions provided by your oncologist or healthcare provider. They will determine the appropriate dosage, schedule, and duration of treatment based on your specific condition.
  • Administration: Rybrevant is typically administered by a healthcare professional through intravenous infusion. This is usually done in a clinical setting such as a hospital or infusion center.
  • Pre-treatment Evaluation: Before starting Rybrevant, your healthcare team may perform various tests and evaluations to assess your overall health and determine the suitability of the medication for your specific case.
  • Monitoring: Regular monitoring will be necessary during the course of treatment to assess the drug’s effectiveness and to manage any potential side effects. Be sure to attend all scheduled appointments and inform your healthcare provider of any concerning symptoms.
  • Adverse Effects: Like any medication, Rybrevant may cause side effects. Common side effects may include skin rash, infusion-related reactions, diarrhea, and others. It’s important to report any side effects promptly to your healthcare provider.
  • Compliance: Adhere to the prescribed treatment plan and schedule. If you have any concerns about the medication or experience side effects, contact your healthcare provider immediately.

Remember, the information provided here is general and may not cover all aspects of Rybrevant use. Always defer to your healthcare provider’s recommendations and consult with them for the most accurate and current information based on your specific medical condition.

Other uses for this medicine

As of last update, Rybrevant is primarily indicated for the treatment of NSCLC with the KRAS G12C mutation. There might be ongoing research or new indications for its use, so it’s essential to check the latest medical information.

What special precautions should I follow?

Special precautions that should be considered when using Rybrevant may include:

  • Patient Assessment: Before starting Rybrevant, a comprehensive patient assessment is typically conducted to evaluate overall health, medical history, and the specific characteristics of the cancer being treated.
  • Allergic Reactions: Patients receiving Rybrevant may be at risk of infusion-related reactions, including hypersensitivity or allergic reactions. Healthcare providers usually monitor patients closely during and after the infusion for any signs of such reactions.
  • Skin Rash: Rybrevant may be associated with skin reactions, including rash. Patients should be monitored for skin changes, and any concerning reactions should be reported to the healthcare provider.
  • Interstitial Lung Disease (ILD): ILD has been reported as a potential side effect of Rybrevant. Patients should be monitored for symptoms such as cough, dyspnea, and fever, and any signs of ILD should be promptly reported.
  • Pregnancy and Breastfeeding: The effects of Rybrevant on pregnancy and breastfeeding are not well-established. Patients should discuss their pregnancy or breastfeeding status with their healthcare provider before starting treatment.
  • Interactions with Other Medications: Inform your healthcare provider about all medications, including prescription, over-the-counter, and herbal supplements, that you are taking. Some medications may interact with Rybrevant.
  • Regular Monitoring: Regular medical monitoring is essential during the course of treatment to assess the drug’s effectiveness and manage potential side effects.

These are general precautions, and specific recommendations may vary based on individual patient factors and the latest medical guidelines. Always consult with your healthcare provider for personalized information regarding the use of Rybrevant, including any updates or changes to its indications and precautions.

What special dietary instructions should I follow?

There were no specific dietary instructions provided for Rybrevant. However, it’s crucial to follow any dietary guidelines or restrictions given by your healthcare provider. Some medications may be taken with or without food, and your healthcare team will provide specific instructions based on the characteristics of Rybrevant.

What should I do if I forget a dose?

If you miss a scheduled dose of Rybrevant, contact your healthcare provider or healthcare team immediately. They will provide guidance on the appropriate course of action. It is not recommended to take a double dose to make up for a missed one, as this can increase the risk of side effects.

What side effects can this medication cause?

Rybrevant (amivantamab) is a medication used in the treatment of non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations. Like many medications, Rybrevant can cause side effects. It’s important to note that the severity and prevalence of side effects can vary among individuals. Common side effects and potential adverse reactions associated with Rybrevant may include:

  • Infusion-Related Reactions: This can include symptoms such as fever, chills, nausea, fatigue, headache, and others. Infusion-related reactions are typically managed by slowing down or temporarily interrupting the infusion and providing appropriate medical interventions.
  • Skin Reactions: Rash and other skin-related issues may occur. It’s important to inform your healthcare provider if you notice any skin changes or rashes.
  • Gastrointestinal Symptoms: Nausea, diarrhea, and vomiting are among the gastrointestinal symptoms that may be associated with Rybrevant.
  • Fatigue: Feeling tired or experiencing fatigue is a common side effect.
  • Decreased Appetite: Some individuals may experience a decreased appetite while taking Rybrevant.
  • Increased Liver Enzymes: Elevated levels of liver enzymes may occur and are typically monitored through blood tests.
  • Interstitial Lung Disease (ILD): While less common, ILD is a serious potential side effect. Symptoms may include difficulty breathing, cough, and fatigue. It’s essential to seek medical attention promptly if any respiratory symptoms develop.

It’s important to promptly report any side effects or concerns to your healthcare provider. They can provide guidance on managing side effects and may adjust the treatment plan if necessary. In some cases, dose modifications or temporary discontinuation may be considered.

This is not an exhaustive list, and individual responses to medications can vary. Always consult with your healthcare provider or refer to the prescribing information for Rybrevant for the most comprehensive and up-to-date information on potential side effects and adverse reactions.

What should I know about storage and disposal of this medication?

Storage of Rybrevant:

  • Temperature: Rybrevant may need to be stored at a specific temperature. Check the medication packaging or consult with your healthcare provider for precise storage instructions.
  • Refrigeration: Some medications, especially those administered intravenously, may require refrigeration. If so, store Rybrevant in the refrigerator as directed.
  • Protect from Light: Certain medications can be sensitive to light. Ensure that Rybrevant is stored in a container that protects it from light if required.

Disposal of Rybrevant:

Proper disposal of medications is essential to prevent accidental exposure and environmental contamination. Here are general guidelines:

  • Follow Local Regulations: Dispose of Rybrevant according to local regulations and guidelines for the disposal of hazardous waste or medications.
  • Return to Healthcare Provider: Some healthcare facilities may have specific procedures for the disposal of unused medications. Check with your healthcare provider or clinic to determine if they can handle the disposal.
  • Drug Take-Back Programs: Many communities have drug take-back programs or events where you can drop off unused medications for proper disposal. Check with local pharmacies or law enforcement agencies for information on such programs.

In case of emergency/overdose

In the case of an emergency or suspected overdose, contact your local poison control center or emergency room immediately. If possible, have the medication container or information available to provide details on the medication.

What other information should I know?

  • Regular Monitoring: Your healthcare provider will likely schedule regular check-ups and monitoring to assess the effectiveness of Rybrevant and monitor for any potential side effects.
  • Follow Healthcare Provider’s Instructions: Always follow the instructions provided by your healthcare provider regarding the administration of Rybrevant, including dosage, infusion schedule, and any special precautions.
  • Informing Healthcare Providers: Keep your healthcare provider informed about any other medications, supplements, or herbal products you are taking, as these may interact with Rybrevant.
  • Patient Education: Stay informed about the potential side effects of Rybrevant and report any unusual symptoms or side effects to your healthcare provider promptly.

This information is intended as a general guide, and specific recommendations may vary based on individual circumstances and the most recent medical information. Always consult with your healthcare provider for personalized advice and the latest guidance on the use, storage, and disposal of Rybrevant.

Copyright © 2023